Physician profile
Jan Hendrickson
NPI 1811520802
$855.09
in general payments reported to CMS, 2019-2025
13 companies · $456 in 2025
The $456 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $83.32 · 2024: $316 · 2025: $456.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $855.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $855.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Viiv Healthcare Company | $292.04 | 2023-2025 | Dovato, Apretude, Cabenuva |
| Gilead Sciences, INC. | $143.84 | 2025 | |
| Merck Sharp & Dohme LLC | $117.84 | 2023-2025 | Pifeltro, Delstrigo, Dificid |
| Bayer Healthcare Pharmaceuticals INC. | $47.11 | 2023-2024 | |
| Pfizer INC. | $46.07 | 2024-2025 | |
| Inspire Medical Systems, INC. | $45.97 | 2025 | Inspire |
| Astrazeneca Pharmaceuticals LP | $45.63 | 2024-2025 | Breztri, Airsupra |
| Lilly USA, LLC | $31.72 | 2024-2025 | Zepbound, Mounjaro |
| Astellas Pharma US INC | $27.05 | 2025 | Veozah |
| Ultragenyx Pharmaceutical INC. | $15.86 | 2023 | |
| Organon LLC | $14.47 | 2024 | |
| Actelion Pharmaceuticals US, INC. | $13.81 | 2024 | Opsumit, Uptravi |
| Neurocrine Biosciences, INC. | $13.68 | 2024 | Ingrezza |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jan Hendrickson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.